CPT1C and bladder transitional cell carcinoma: The results of clinical correlation analysis indicated that BLCA patients with higher pathological grade, later clinical stage, later TNM stage, and poor treatment efficacy may have high expression of CPT1C, which further proved that the expression of CPT1C was closely related to the development of BLCA (Fig. 11H).